Industry steps up interest in developing world, fueling doubling of R&D pipeline

The pipeline of drugs and vaccines aimed at diseases prevalent in low- and middle-income countries has more than doubled since 2014, according to the Access to Medicine Foundation. However, the trend was driven by surging activity in noncommunicable diseases, leaving many conditions underserved by the current pipeline.